With a solid research and development foundation and GTP laboratory, we have cooperated with several medical institutions for helping clinical cases by applying the Special Regulation for Cell Therapy (SRCTAct) in Taiwan. Moreover, we have applied several approved diseases in SRCT Act, e.g., subcutaneous and soft tissue defects, osteoarthritis and spinal cord injury, by using autologous mesenchymal stem cells to bring patients a better life.
